Session Information
241st ACS National Meeting & Exposition
Click here to go to the previous page
Discovery and development of LX1031, a novel serotonin synthesis inhibitor for the treatment of irritable bowel syndrome
Track
:
First Time Disclosure of Clinical Candidate
Program Code:
35-02-0030
Date:
Sunday, March 27, 2011
Time:
2:40 PM to 3:00 PM
EST
Location:
ACC-Ballroom A,B,C
SPEAKER
:
Alan Main
Description
One Minute Survey on the Online Content
For optimal viewing capability, please download the most up to date version of Adobe Flash Player here.
For optimal viewing capability, please download the most up to date version of Adobe Flash Player here.
Audio Synchronized to PowerPoint
